Generalizable design parameters for soluble T cell receptor-based T cell engagers

Karen Froning(Eli Lilly (United States)), Stephen J. Demarest(Eli Lilly (United States))
Journal for ImmunoTherapy of Cancer
March 1, 2022
Cited by 4


Related Papers